Extended Data Fig. 5: Generation of various therapeutic immune cells by MAJESTIC. | Nature Biomedical Engineering

Extended Data Fig. 5: Generation of various therapeutic immune cells by MAJESTIC.

From: AAV-mediated delivery of a Sleeping Beauty transposon and an mRNA-encoded transposase for the engineering of therapeutic immune cells

Extended Data Fig. 5

a, Representative flow cytometry plots of NY-ESO-1 T cells. b, Quantification of (a). c, Quantification of the CD22.CAR.iCasp T cell viability. d, Representative flow cytometry plots of CD22.CAR.iCasp9 T cells. e, Quantification of (d). f, Quantification of the CD22.CAR.iCasp9 T cells post antigen-specific cancer cells stimulation. In this figure, each assay has three technical replicates, donor 601c and donor 02 T cells were used in this figure.

Source data

Back to article page